Spineway — Regulatory Filings 2017

Jun 14, 2017

SPINEWAY records a new \$1M order in the USA

Spineway, specialist in surgical implants and instruments for treating disorders of the spinal column (spine), has obtained a new order via its California partner amounting to \$1M.

This order, recorded by the Group's US subsidiary, Spineway USA Inc., will be fulfilled in the next few weeks. It concerns the Mont-Blanc, Twin Peaks, Blue Mountain and Ayers Rocks product lines and shows US surgeons' increasing interest in Spineway's products.

With \$3M in orders received in eight months, Spineway confirms the rise of its US subsidiary and reconfirms its ambition to generate a significant portion of its revenue from the US market.

SPINEWAY IS ELIGIBLE FOR THE PEA-PME (EQUITY SAVINGS PLAN FOR SMES) Find out all about Spineway at www.spineway.com

Next communication: 2017 First Semester Sales – 18 July 2017, after market closes

Spineway designs, manufactures and markets innovative implants and surgical instruments for treating severe disorders of the spinal column. Spineway has an international network of over 50 independent distributors and 90% of its turnover comes from exports. Spineway, which is eligible for investment through FCPIs (French unit trusts specializing in innovation), received the OSEO Excellence award as well as the Deloitte Fast 50 award in 2011. Rhône Alpes INPI Patent Innovation Award (2013) – Talent INPI award (2015). ISIN code: FR0011398874 - ALSPW

Investor Relations David Siegrist – Finance Director Tel: +33 (0)4 72 77 01 52 finance.dsg@spineway.com

Financial Communication Jérôme Gacoin / Solène Kennis Tel: +33 (0)1 75 77 54 68 skennis@aelium.fr